Moncef Slaoui, chairman of GSK research and development, said bioelectronics was set to be the next big wave in medicine, comparable to the rise in biological therapies over the past 15 years triggered by advances in biotechnology.

It is ambitious work but there have been impressive strides in bringing together biology and computers recently, such the case of a 58-year-old paralyzed woman who last year used an experimental brain-computer interface to move a robotic arm by thought alone.

https://www.reuters.com/article/us-glaxosmithkline-electroceuticals/gsk-plans-1-million-prize-to-jump-start-electroceuticals-idUSBRE9390VM20130410/